Literature DB >> 32757740

Interleukin-4 improves white matter integrity and functional recovery after murine traumatic brain injury via oligodendroglial PPARγ.

Hongjian Pu1,2, Xuan Zheng2, Xiaoyan Jiang1,2, Hongfeng Mu2, Fei Xu1,2, Wen Zhu2, Qing Ye1,2, Yunneng Jizhang2, T Kevin Hitchens3,4, Yejie Shi1,2, Xiaoming Hu1,2, Rehana K Leak5, C Edward Dixon1,6, Michael Vl Bennett7, Jun Chen1,2.   

Abstract

Long-term neurological recovery after severe traumatic brain injury (TBI) is strongly linked to the repair and functional restoration of injured white matter. Emerging evidence suggests that the anti-inflammatory cytokine interleukin-4 (IL-4) plays an important role in promoting white matter integrity after cerebral ischemic injury. Here, we report that delayed intranasal delivery of nanoparticle-packed IL-4 boosted sensorimotor neurological recovery in a murine model of controlled cortical impact, as assessed by a battery of neurobehavioral tests for up to five weeks. Post-injury IL-4 treatment failed to reduce macroscopic brain lesions after TBI, but preserved the structural and functional integrity of white matter, at least in part through oligodendrogenesis. IL-4 directly facilitated the differentiation of oligodendrocyte progenitor cells (OPCs) into mature myelin-producing oligodendrocytes in primary cultures, an effect that was attenuated by selective PPARγ inhibition. IL-4 treatment after TBI in vivo also failed to stimulate oligodendrogenesis or improve white matter integrity in OPC-specific PPARγ conditional knockout (cKO) mice. Accordingly, IL-4-afforded improvements in sensorimotor neurological recovery after TBI were markedly impaired in the PPARγ cKO mice compared to wildtype controls. These results support IL-4 as a potential novel neurorestorative therapy to improve white matter functionality and mitigate the long-term neurological consequences of TBI.

Entities:  

Keywords:  OPC differentiation; PPARγ; Traumatic brain injury; oligodendrogenesis; white matter injury/integrity

Mesh:

Substances:

Year:  2020        PMID: 32757740      PMCID: PMC7922743          DOI: 10.1177/0271678X20941393

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  53 in total

Review 1.  Post-stroke administration of omega-3 polyunsaturated fatty acids promotes neurovascular restoration after ischemic stroke in mice: Efficacy declines with aging.

Authors:  Xiaoyan Jiang; Jun Suenaga; Hongjian Pu; Zhishuo Wei; Amanda D Smith; Xiaoming Hu; Yejie Shi; Jun Chen
Journal:  Neurobiol Dis       Date:  2018-09-12       Impact factor: 5.996

2.  Bexarotene protects against neurotoxicity partially through a PPARγ-dependent mechanism in mice following traumatic brain injury.

Authors:  Junchi He; Han Liu; Jianjun Zhong; Zongduo Guo; Jingchuan Wu; Hongrong Zhang; Zhijian Huang; Li Jiang; Hui Li; Zhaosi Zhang; Liu Liu; Yue Wu; Lingjun Qi; Xiaochuan Sun; Chongjie Cheng
Journal:  Neurobiol Dis       Date:  2018-06-07       Impact factor: 5.996

3.  A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice.

Authors:  M Falcone; A J Rajan; B R Bloom; C F Brosnan
Journal:  J Immunol       Date:  1998-05-15       Impact factor: 5.422

Review 4.  Myelin and oligodendrocyte lineage cells in white matter pathology and plasticity after traumatic brain injury.

Authors:  Regina C Armstrong; Amanda J Mierzwa; Genevieve M Sullivan; Maria A Sanchez
Journal:  Neuropharmacology       Date:  2015-05-09       Impact factor: 5.250

5.  The Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI): I. Construct validity.

Authors:  Elisabeth A Wilde; Stephen R McCauley; Tara M Kelly; Annie M Weyand; Claudia Pedroza; Harvey S Levin; Guy L Clifton; Kathleen P Schnelle; Monika V Shah; Paolo Moretti
Journal:  J Neurotrauma       Date:  2010-06       Impact factor: 5.269

6.  Increased brain injury and worsened neurological outcome in interleukin-4 knockout mice after transient focal cerebral ischemia.

Authors:  Xiaoxing Xiong; George E Barreto; Lijun Xu; Yi Bing Ouyang; Xinmin Xie; Rona G Giffard
Journal:  Stroke       Date:  2011-05-19       Impact factor: 7.914

7.  Regulation of learning and memory by meningeal immunity: a key role for IL-4.

Authors:  Noël C Derecki; Amber N Cardani; Chun Hui Yang; Kayla M Quinnies; Anastasia Crihfield; Kevin R Lynch; Jonathan Kipnis
Journal:  J Exp Med       Date:  2010-05-03       Impact factor: 14.307

8.  Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury.

Authors:  Kristen N Segovia; Melissa McClure; Matthew Moravec; Ning Ling Luo; Ying Wan; Xi Gong; Art Riddle; Andrew Craig; Jaime Struve; Larry S Sherman; Stephen A Back
Journal:  Ann Neurol       Date:  2008-04       Impact factor: 10.422

9.  Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor.

Authors:  Sarah C Hellewell; Edwin B Yan; Dasuni S Alwis; Nicole Bye; M Cristina Morganti-Kossmann
Journal:  J Neuroinflammation       Date:  2013-12-18       Impact factor: 8.322

Review 10.  Traumatic Axonal Injury: Mechanisms and Translational Opportunities.

Authors:  Ciaran S Hill; Michael P Coleman; David K Menon
Journal:  Trends Neurosci       Date:  2016-03-31       Impact factor: 13.837

View more
  8 in total

1.  STAT1 contributes to microglial/macrophage inflammation and neurological dysfunction in a mouse model of traumatic brain injury.

Authors:  Yongfang Zhao; Cheng Ma; Caixia Chen; Sicheng Li; Yangfan Wang; Tuo Yang; R Anne Stetler; Michael V L Bennett; C Edward Dixon; Jun Chen; Yejie Shi
Journal:  J Neurosci       Date:  2022-08-18       Impact factor: 6.709

Review 2.  Microglia as the Critical Regulators of Neuroprotection and Functional Recovery in Cerebral Ischemia.

Authors:  Bhakta Prasad Gaire
Journal:  Cell Mol Neurobiol       Date:  2021-08-30       Impact factor: 4.231

3.  Treatment with an Angiopoietin-1 mimetic peptide promotes neurological recovery after stroke in diabetic rats.

Authors:  Poornima Venkat; Ruizhuo Ning; Alex Zacharek; Lauren Culmone; Linlin Liang; Julie Landschoot-Ward; Michael Chopp
Journal:  CNS Neurosci Ther       Date:  2020-12-21       Impact factor: 7.035

4.  Genetic Deficiency of MicroRNA-15a/16-1 Confers Resistance to Neuropathological Damage and Cognitive Dysfunction in Experimental Vascular Cognitive Impairment and Dementia.

Authors:  Chao Zhou; Ping Sun; Yang Xu; Yuang Chen; Yixian Huang; Milton H Hamblin; Lesley Foley; T Kevin Hitchens; Song Li; Ke-Jie Yin
Journal:  Adv Sci (Weinh)       Date:  2022-04-11       Impact factor: 17.521

5.  Microglia-specific deletion of histone deacetylase 3 promotes inflammation resolution, white matter integrity, and functional recovery in a mouse model of traumatic brain injury.

Authors:  Yongfang Zhao; Hongfeng Mu; Yichen Huang; Sicheng Li; Yangfan Wang; R Anne Stetler; Michael V L Bennett; C Edward Dixon; Jun Chen; Yejie Shi
Journal:  J Neuroinflammation       Date:  2022-08-06       Impact factor: 9.587

Review 6.  Phagocytic microglia and macrophages in brain injury and repair.

Authors:  Fang Yu; Yangfan Wang; Anne R Stetler; Rehana K Leak; Xiaoming Hu; Jun Chen
Journal:  CNS Neurosci Ther       Date:  2022-06-25       Impact factor: 7.035

7.  Baicalin Promotes CNS Remyelination via PPARγ Signal Pathway.

Authors:  Ruo-Song Ai; Kun Xing; Xin Deng; Juan-Juan Han; Dong-Xia Hao; Wen-Hui Qi; Bing Han; Ya-Na Yang; Xing Li; Yuan Zhang
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-02-01

8.  Intranasal delivery of interleukin-4 attenuates chronic cognitive deficits via beneficial microglial responses in experimental traumatic brain injury.

Authors:  Hongjian Pu; Cheng Ma; Yongfang Zhao; Yangfan Wang; Wenting Zhang; Wanying Miao; Fang Yu; Xiaoming Hu; Yejie Shi; Rehana K Leak; T Kevin Hitchens; C Edward Dixon; Michael Vl Bennett; Jun Chen
Journal:  J Cereb Blood Flow Metab       Date:  2021-07-14       Impact factor: 6.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.